The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular The peptide problem: Hype is outrunning the evidence Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Medicine Springer Nature Link FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times